Opening Recap Market Pulse: Markets edged lower as listed REITs outperformed dying realty stocks and crypto markets wobbled after mixed signals. Key Movers: The Times of India reports REITs delivering up to 29% returns while...
Latest articles
INVESTOR ALERT: AGIO Faces Major Legal Scrutiny Now!
Company Overview Agios Pharmaceuticals (NASDAQ: AGIO) is a biotech company focused on developing therapies for rare genetic diseases, notably through activating pyruvate kinase (PK) enzymes ([1]). The company already markets a...
Daily Market Recap: BNB, AVAX, Solana in Focus
Wednesday, September 24, 2025 Market Pulse: Equities and crypto held steady after Fed’s Bowman stoked chatter about quicker rate cuts, leaving traders in a wait-and-see mood. Key Movers: Binance Coin bulls eye a move to $1,200...
“UMB Bank’s Bold Move: Why $COR Could Skyrocket Now!”
Introduction Cencora, Inc. (NYSE: COR), formerly AmerisourceBergen, is drawing fresh attention after UMB Bank n.a. made a bold move by boosting its stake in the company. In a recent SEC filing, UMB Bank disclosed a 6.9% increase...
PSU Banks Soar, Crypto Meltdown: Your Market Brief
Daily Financial Update Market Pulse: Stocks are on a sector rotation tear as PSU banks and defence contractors outshine broader markets, even as digital assets remain under pressure. Key Movers: STRS Ohio’s move to snap up 54,900...
“Goldman Just Sold IMNM: What They Know That You Don’t!”
Company Overview of IMNM (Immunome, Inc.) Immunome, Inc. (NASDAQ: IMNM) is a clinical-stage biotechnology company focused on oncology, developing therapies across multiple modalities (antibodies, ADCs, radioligands, etc.) ([1])...
Fed Easing Sparks Crypto Surge and Stock Rally
Opening Recap Market Pulse: Markets ripped higher on signs of Fed easing with broad risk-on flows in crypto and equities, even though SPX saw a choppy session around critical support. Key Movers: Bitcoin shrugged off its seasonal...
REPL: FDA Approval Uncertainty Sparks 39% Nosedive!
Replimune Group, Inc. (NASDAQ: REPL) is a clinical-stage biotechnology company developing oncolytic immunotherapies—engineered viruses that selectively infect and kill cancer cells and stimulate anti-tumor immunity ([1]). The...
Stocks and Crypto Rally: Fed Cut Hype Explained
Opening Recap Market Pulse: Equities and crypto ripped higher on whispers of a Fed cut, fueling fresh breakouts in both small caps and digital assets. Key Movers: CDSL’s 42% six-month surge led stock chatter, while the new REX...
BNC: $250M Buyback—Why This Could Skyrocket Shares!
Overview – BNC’s Bold Pivot and Buyback Catalyst BNC (officially CEA Industries Inc., Nasdaq: BNC) has transformed from a small agricultural engineering firm into a crypto asset holding company, now branding itself as the “BNB...